Herreros-Villanueva M - Search Results

1

KRAS mutations: analytical considerations.

Herreros-Villanueva M, Chen CC, Yuan SS, Liu TC, Er TK. Herreros-Villanueva M, et al. Clin Chim Acta. 2014 Apr 20;431:211-20. doi: 10.1016/j.cca.2014.01.049. Epub 2014 Feb 15. Clin Chim Acta. 2014. PMID: 24534449 Review.

2

Endometriosis-associated ovarian cancer: What have we learned so far?

Herreros-Villanueva M, Chen CC, Tsai EM, Er TK. Herreros-Villanueva M, et al. Clin Chim Acta. 2019 Jun;493:63-72. doi: 10.1016/j.cca.2019.02.016. Epub 2019 Feb 15. Clin Chim Acta. 2019. PMID: 30776361 Review.

3

Computational analysis of KRAS mutations: implications for different effects on the KRAS p.G12D and p.G13D mutations.

Chen CC, Er TK, Liu YY, Hwang JK, Barrio MJ, Rodrigo M, Garcia-Toro E, Herreros-Villanueva M. Chen CC, et al. PLoS One. 2013;8(2):e55793. doi: 10.1371/journal.pone.0055793. Epub 2013 Feb 20. PLoS One. 2013. PMID: 23437064 Free PMC article.

4

Clinical relevance of KRAS mutations in codon 13: Where are we?

Er TK, Chen CC, Bujanda L, Herreros-Villanueva M. Er TK, et al. Cancer Lett. 2014 Feb 1;343(1):1-5. doi: 10.1016/j.canlet.2013.09.012. Epub 2013 Sep 16. Cancer Lett. 2014. PMID: 24051306 Review.

5

Current approaches for predicting a lack of response to anti-EGFR therapy in KRAS wild-type patients.

Er TK, Chen CC, Bujanda L, Herreros-Villanueva M. Er TK, et al. Biomed Res Int. 2014;2014:591867. doi: 10.1155/2014/591867. Epub 2014 Jun 18. Biomed Res Int. 2014. PMID: 25032217 Free PMC article. Review.

6

Immunotherapy in colorectal cancer: What have we learned so far?

Sanchez-Castañón M, Er TK, Bujanda L, Herreros-Villanueva M. Sanchez-Castañón M, et al. Clin Chim Acta. 2016 Sep 1;460:78-87. doi: 10.1016/j.cca.2016.06.027. Epub 2016 Jun 24. Clin Chim Acta. 2016. PMID: 27350293 Review.

7

Retinoic Acid Reduces Stem Cell-Like Features in Pancreatic Cancer Cells.

Herreros-Villanueva M, Er TK, Bujanda L. Herreros-Villanueva M, et al. Pancreas. 2015 Aug;44(6):918-24. doi: 10.1097/MPA.0000000000000373. Pancreas. 2015. PMID: 26035122

8

Molecular characterization of oral squamous cell carcinoma using targeted next-generation sequencing.

Er TK, Wang YY, Chen CC, Herreros-Villanueva M, Liu TC, Yuan SS. Er TK, et al. Oral Dis. 2015 Oct;21(7):872-8. doi: 10.1111/odi.12357. Epub 2015 Aug 6. Oral Dis. 2015. PMID: 26173098

9

Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.

Er TK, Su YF, Wu CC, Chen CC, Wang J, Hsieh TH, Herreros-Villanueva M, Chen WT, Chen YT, Liu TC, Chen HS, Tsai EM. Er TK, et al. J Mol Med (Berl). 2016 Jul;94(7):835-47. doi: 10.1007/s00109-016-1395-2. Epub 2016 Feb 27. J Mol Med (Berl). 2016. PMID: 26920370

10

No evidence for JAK2 V617F mutation in colorectal cancer.

Herreros-Villanueva M, Garcia-Girón C, Er TK. Herreros-Villanueva M, et al. Br J Biomed Sci. 2010;67(4):220-2. doi: 10.1080/09674845.2010.11978229. Br J Biomed Sci. 2010. PMID: 21294452 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page